Medical imaging firm Analogic has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SonixGPS nerve block needle kit.
The nerve block needles are used with Analogic's SonixGPS ultrasound technology, which is designed for guidance procedures such as nerve blocks for pain management and surgery.
The SonixGPS ultrasound guidance system uses multiple position sensors, including one embedded in the transducer, to provide ultrasound guidance, potentially reducing the learning curve for procedures such as nerve blocks, vascular access, core biopsies, and fine-needle aspirations. Physicians can insert the needle from any direction, including in-plane with the transducer or out of plane. As a result, trajectory may be planned before inserting the needle to reduce unnecessary tissue manipulation while maintaining patient comfort, Analogic said.
The kits are available on the SonixTouch and SonixTablet ultrasound systems, which are equipped with a customizable touchscreen interface.
Analogic is highlighting the new technology, as well as showcasing its SonixTouch ultrasound research system, OEM transducers, and OEM ultrasound platform at the American Institute of Ultrasound in Medicine (AIUM) meeting taking place in Las Vegas this week.
